Regarding AD, numerous molecules have also been developed as MTDLs, being able to act as enzyme inhibitors and receptor ligands towards several targets, including cholinesterase enzymes (AChE and BuChE), Aβ peptides, hyperphosphorylated τ protein, amongst others [30]. The gene discussed is ACHE; the disease is Alzheimer disease.